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Abstract
Background: Recently, it has been assumed that resistance of Plasmodium to chloroquine
increased malaria mortality. The study aimed to assess the impact of chemoresistance on mortality
attributable to malaria in a rural area of Senegal, since the emergence of resistance in 1992, whilst
chloroquine was used as first-line treatment of malaria, until the change in national anti-malarial
policy in 2003.
Methods: The retrospective study took place in the demographic surveillance site (DSS) of
Niakhar. Data about malaria morbidity were obtained from health records of three health care
facilities, where diagnosis of malaria was based on clinical signs. Source of data concerning malaria
mortality were verbal autopsies performed by trained fieldworkers and examined by physicians
who identified the probable cause of death.
Results: From 1992 to 2004, clinical malaria morbidity represented 39% of total morbidity in
health centres. Mean malaria mortality was 2.4‰ and 10.4‰ among total population and children
younger than five years, respectively, and was highest in the 1992-1995 period. It tended to decline
from 1992 to 2003 (Trend test, total population p = 0.03, children 0-4 years p = 0.12 - children 1-
4 years p = 0.04- children 5-9 years p = 0.01).
Conclusion: Contrary to what has been observed until 1995, mortality attributable to malaria did
not continue to increase dramatically in spite of the growing resistance to chloroquine and its use
as first-line treatment until 2003. Malaria morbidity and mortality followed parallel trends and
rather fluctuated accordingly to rainfall.
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While childhood mortality is decreasing in Africa,
malaria-specific mortality remains an alarming public
health issue [1,2]. Moreover, resistance to chloroquine
(CQ), which emerged in the 1980s, was considered
responsible for a dramatic increase of malaria-specific
mortality since the 1990s [3]. In the Senegalese Demo-
graphic Surveillance Site (DSS) of Niakhar, located in the
region and department of Fatick, Trape et al [3,4] showed
that malaria mortality among children of less than five
years of age increased from 5.4‰ in 1988-1991 to
12.4‰ in 1992-1995, and attributed it to the emergence
of CQ resistance in 1992.
In the DSS of Niakhar, in vivo tests conducted in 1993,
1994 and 1995 in Diohine village (Figure 1) showed 10-
17% resistance rates of RII and RIII types at day 7 after CQ
treatment, and 30-42% resistance rates at day 14 [5]. In
other villages in the region of Fatick, 80 km from Niakhar
DSS, Pradines et al [6] (1995) found 29% of all isolated
strains resistant in vitro to CQ. In 1996, Sokhna et al [7]
observed an in vivo resistance of 44% measured at day 14,
in Diohine village. Additional studies conducted in a sen-
tinel site located in the region of Kaolack, 60 km from
Niakhar DSS, showed increasing in vivo resistance rates
from 26% in 1998 to 42% in 2001 at day 14 [8].
The Senegalese national policy only replaced CQ as first-
line treatment of malaria by the association amodi-
aquine/sulphadoxine-pyrimethamine (AQ/SP) in 2003.
Meanwhile, the follow-up of the DSS of Niakhar popula-
tion continued, aiming to describe and investigate the
causes of mortality in the population, including children,
in order to provide demographic and health data, and rec-
ommend preventive strategies.
This study attempts to evaluate retrospectively the influ-
ence of chemoresistance on the mortality attributable to
Niakhar study areaFigure 1
Niakhar study area.Page 2 of 9
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which CQ resistance increased, whilst CQ remained the
first-line treatment of malaria.
Methods
Study area and population
The Niakhar DSS, located in the region and the depart-
ment of Fatick, 130 km south-east of Dakar in Senegal [9],
is a demographic surveillance site since 1963, currently
composed of 30 villages (Figure 1). It covers 230 square
km and counted an average of 30,000 inhabitants
between 1992 and 2004. Demographic (births, deaths,
marriages, migrations) and various data (child vaccina-
tions, economic incomes, child education, and daily rain-
falls) were collected by permanent fieldworkers.
Three dispensaries situated in the villages of Diohine,
Toucar and Ngayokhem, carried out basic health services
to the population, including curative, preventive and pre-
natal care, birth deliveries, and vaccination. A nurse was in
charge of the consultations and was assisted by a commu-
nity health worker and a drug provider.
Cause of death
It was assumed that the increase of mortality resulting
from chloroquine resistance should be linked to propor-
tional increase of malaria case-fatality rate. In the Niakhar
DSS population, mortality is well addressed and causes of
death are established through systematic and standard-
ized verbal autopsy. Although data about deaths occur-
ring among malarial patients consulting in health
dispensaries were not available, malaria morbidity was
estimated from the registers of dispensaries.
Other causes able to change the malaria transmission rate
were also checked, including rainfall or interventions such
as vector control in the studied area.
Data collection
Death registration was performed by surveys consisting in
domiciliary visits to all households of the DSS, conducted
weekly from 1987 to 1996 and on a quarterly basis from
1997 onwards [10]. These surveys enabled fieldworkers to
identify deaths occurring since their last visit. They
informed the supervisor who sent an agent within the fol-
lowing three months in the specified households to real-
ize a verbal autopsy. It consisted in a post-mortem
investigation based on an interview conducted by the
agent with the relatives of the deceased, usually one of the
parents in case of a child's death. A standardized question-
naire containing identification of the person, history of
symptoms and illness, and declared cause of death by the
family, was completed by the fieldworker and subse-
quently reviewed by two physicians independently [11],
who each identified the most probable cause of death. In
case of discordant diagnosis, a group of three or four phy-
sicians discussed the cases to reach a consensus. Causes of
death were coded using the International Classification of
Diseases from the World Health Organization (WHO/
ICD-9). The same methodology was used during the
entire period of the study, regarding verbal autopsy ques-
tionnaire and attribution of death causes.
Morbidity data were drawn from health records of the
three health care facilities. The records were completed by
the nurse during the consultation, indicating the name of
the patient, age, sex and village of residence, observed
symptoms, clinical diagnosis and prescribed treatment.
Registers from 1992 to 2004 were collected retrospec-
tively.
Malaria diagnosis mainly relied on clinical signs as health
centres lacked laboratory facilities or rapid diagnostic
tools. Thus, terms of "malaria diagnosis" or "malaria mor-
bidity" here refer to presumptive malaria not confirmed
parasitologically. "Fever" is reported on the health record
by the nurse, independently from the measure of temper-
ature, whereas the "body temperature" is the temperature
in Celsius degrees, measured by the nurse with a ther-
mometer during the consultation.
Daily rainfalls were provided by a pluviometer located in
the village of Niakhar, at the station of the IRD research
institute and entered in Excel® 2003 (Microsoft Corpora-
tion, Redmond, WA, USA).
Data processing and analysis
Morbidity data from health records were entered in dBase
IV® (dataBased Intelligence, Inc., Vestal, NY, USA). Annual
number of consultations was reported to person-year (py)
at risk in the study zone (expressed in number of consul-
tations per 1,000 inhabitants) from 1992 to 2004. These
demographic data were provided by the original Niakhar
DSS database used for the prospective follow-up of the
population.
Mortality data were entered in the database (dBase IV®
until 2003, and Access® from 2003, Microsoft Corpora-
tion, Redmond, WA, USA) and analysed by the IRD team
in Dakar.
Statistical analyses were performed using Stata 8.0® soft-
ware, StataCorp LP, Texas, USA. The comparison of quan-
titative variables was made by the Student t test.
Proportions between groups (malaria diagnosis vs. non
malaria) were compared using univariate logistic regres-
sion. Odds-ratio (OR) were given with their 95% confi-
dence intervals (CI). Trends in malaria mortality betweenPage 3 of 9
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2003) were analysed using the Cuzick trend test. Statisti-
cal significance was set to p = 0.05.
Results
Morbidity
A total of 110,093 consultations were reported between
1992 and 2004 in the three health care facilities. Malaria
was clinically diagnosed in 43,232 patients (39.3%).
Characteristics of the patients
Overall male/female ratio was 0.83, females representing
54.7% of patients, but masculine gender was predomi-
nant before 15 years of age. Mean age was 17.5 years
(median = 9 years, difference between genders: male = 6
vs. female = 13).
Children under 15 represented 56.8% of the consulta-
tions. Regarding consultations for malaria, 1-4 year-old
children consulted in a greater number, followed by 0-1
year, 5-14s, 15-54s and, finally, above 54 years of age.
Children aged one to 14 had an increased risk to be diag-
nosed malaria than another diagnosis by the nurse (1-4
years-old: OR = 1.34 (CI: 1.31-1.38), 5-14 years-old: OR =
2.21 (CI: 2.15-2.28)). The rainy season (from August to
November) accounted for 65% of malaria cases, with 27%
in October alone.
Positive predictive signs of a clinical diagnosis of malaria
by the nurse were fever (OR = 5.23, IC [5.08-5.40],
malaria vs. non-malaria diagnosis), convulsions (4.24
[3.57-5.04]), malnutrition (5.29 [4.99-5.60]), vomiting
(5.62 [5.42-5.83]), headache (10.04 [9.70-10.39]) and
chills (29.5 [25.6-34.0]). The mean body temperature was
significantly higher among patients with a clinical diagno-
sis of malaria than non-malarial patients (38.0 vs. 37.2°C,
p < 10-5).
Evolution of morbidity and rainfalls between 1992 and 2004
Malaria and non-malaria morbidity followed similar
trends over the time. Mean of all cause morbidity was
284‰ persons-years between 1992 and 2004, malaria
and non-malaria counting respectively for 112‰ and
172‰. Malaria cases reached 150‰ in 2001, represent-
ing 49% of total morbidity that year, and fell to 84‰ in
2004. A drop in the total number of consultations
occurred in 1997 (230‰), mainly attributed to a decrease
in malaria-specific morbidity (81‰) (Figure 2).
The average rainfall between 1992 and 2004 was 463.5
mm per year. From 1992, rainfall increased to reach a
maximum in 1995 (631.7 mm) (Figure 3). In 1997, a
drop of rainfall preceded the fall in malaria morbidity.
Besides, between 1999 and 2001, consultations for
malaria reached a maximum (mean 144‰), while rain-
fall was at a high level (mean 547.8 mm).
Mortality
Overall and malaria-specific annual mortality were
respectively 15.1‰ and 2.4‰. A peak in overall mortal-
ity occurred in 1998 (23.6‰), then it decreased until
2004 (9.6‰). Mortality attributable to malaria followed
the same general tendency, but presented two peaks, in
1995 (3.6‰) and 2002 (2.9‰). Malaria mortality fell to
1‰ in 2004 (Figure 2).
Mean mortality attributable to malaria among children
aged 0-4, 5-9 and 10-14 years was respectively 10.4‰,
2.2‰ and 0.3‰, between 1992 and 2004, and counted
for 26.6%, 37.1% and 10.3% of overall mortality in those
age groups (Table 1).
Evolution of consultations for malaria in health care facilities and deaths attributable to malaria in Niakh r are  (1992-2004)Figure 2
Evolution of consultations for malaria in health care 
facilities and deaths attributable to malaria in Nia-
khar area (1992-2004). The purple line represents the 
clinical malaria morbidity in dispensaries per 1,000 person-
year at risk (py). The orange line represents the malaria mor-
tality per 1,000 py in the population.
Malaria consultations and annual rainfall in Niakhar area, 1992-2004Figu e 3
Malaria consultations and annual rainfall in Niakhar 
area, 1992-2004. The purple line represents the clinical 
malaria morbidity in dispensaries per 1,000 person-year at 
risk (py). The green line represents the annual rainfall (mm) 
in Niakhar village.Page 4 of 9
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1996-1999 and 2000-2003, there was a significant down-
ward trend in malaria mortality among all the population
(children and adults) (Cuzick trend test, p = 0.031).
Among children less than 15 years, malaria mortality pre-
sented a declining trend, although not significant (p =
0.062). It was respectively 12.5‰, 10.6‰ and 9.8‰ for
0-4 years (p = 0.117). Concerning more particularly chil-
dren aged 1 to 4 years, it was respectively 13.3‰, 11.7‰
and 9.0‰ (p = 0.039). It was 3.3‰, 2.0‰ and 1.8‰ for
5-9 years (p = 0.011) and 0.2‰, 0.2‰ and 0.7‰ for 10-
14 years (p = 0.09). In 2004, malaria mortality decreased
to 4.3‰, 0.4‰ and 0.0‰ in each age group respectively.
Although CQ resistance was continuously growing during
the period of study, malaria mortality tended to decline in
the area (Figure 4).
Discussion
Chloroquine resistance is considered as the first cause of
increasing risks of malaria morbidity and mortality in the
world [3,4,12,13]. Two causes could explain why chem-
oresistance could induce an increase of consultations for
malaria in health centres. The very first cause is likely to be
the failure of self-medication that is a common behaviour
in the Niakhar population in order to treat fever before
going either to traditional healer or modern dispensary
[14,15]. However, anti-malarial drugs represented only
18.2% of total self-medication versus 64.7% for antipyret-
ics [15] and chloroquine was seldom available on markets
even though it was a cheap and affordable drug. The sec-
ond cause is likely to be the failure of chloroquine treat-
ment administered by nurses of health centres. The
emergence of CQ resistance results in the return of non-
cured patients for further care within the few days or
weeks following the CQ treatment. One could hypothe-
size that returns of patients treated with chloroquine
should increase proportionally to the CQ resistance. Nev-
ertheless, an ancillary study conducted in the same dis-
pensaries, did not show increasing rates of returns after
CQ treatment during this period [16].
Morbidity data used in this study were based on clinical
malaria which is known to overestimate the number of
malaria cases [17-20]. The main clinical criteria for diag-
nosing malaria did not change over the time in two of the
health centres -representing 84% of total morbidity data-
which allowed to study the main trends. These data indi-
cate a consistency in the practices of health staff. Predic-
tive signs of clinical diagnosis of malaria, such as age of
patient (1-14 years), presence of fever, headache and vom-
iting, and treatments prescribed (varying with the diag-
nosed pathology), showed that nurses followed a
continuous rationale in order to distinguish malaria from
other diseases.
The overall morbidity fluctuated over the period 1992-
2004, showing two peaks in 1996 and 1999, respectively
attributed to a cholera outbreak and both meningitis and
shigellosis epidemics [11]. In 1997, the drop in consulta-
tions for malaria could be linked to the lower rainfall and
lower malaria transmission in the area.
Table 1: Overall mortality and mortality attributable to malaria (deaths per thousand person-year at risk) in Niakhar study area 




0-4 years 5-9 years 10-14 years
Years Overall Malaria Overall Malaria Overall Malaria Overall Malaria
mortality mortality mortality mortality mortality mortality mortality Mortality
(‰) (‰) (‰) (‰) (‰) (‰) (‰) (‰)
1992 21.5 5.08 37.4 10.1 5.5 2.8 2.1 0.30
1993 22.4 6.32 44.4 13.2 5.4 3.2 3.5 0
1994 17.3 5.34 43.6 10.3 6.6 3.7 2.2 0.28
1995 19.2 7.46 33.9 16.3 6.0 3.4 0.3 0
1996 20.1 6.13 72.7 14.0 6.8 1.9 4 0.53
1997 15.4 2.51 65.9 4.7 5.2 2.2 2.7 0
1998 33.0 5.27 46.3 11.6 11.5 2.6 6.8 0.24
1999 29.2 4.87 35.3 12.1 10.5 1.3 5.3 0
2000 20.7 4.3 32.7 9.8 7.9 2.0 3.8 0.23
2001 15.2 3.86 30.2 9.0 4.1 1.1 2.1 0.46
2002 14.1 5.61 18.7 11.9 3.7 2.4 1.6 1.15
2003 13.1 4.12 30.2 8.5 2.2 1.7 2.3 0.91
2004 8.5 1.84 18.7 4.3 1.9 0.4 1.6 0
mean 1992-2004 19.2 4.8 39.2 10.4 5.9 2.2 2.9 0.30Page 5 of 9
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tion of the area could actually explain a higher attendance
at the dispensary. For example, the persistence of the same
nurse since 1996 in one of the public health facilities may
have played an essential role in health-seeking behaviour
of patients, probably contributing to increase the activity
of this centre. Valin et al [21] demonstrated in the same
zone that a follow-up of populations and a free access to
health care with an early treatment of malaria cases were
key elements in the control of malaria, even in a zone of
high resistance to CQ.
While morbidity concerned only patients consulting in
the dispensaries of the DSS, mortality was measured in the
entire population and should be considered as exhaustive
due to the collecting methods. The causes of deceases,
including malaria, were determined by verbal autopsies
(VA) that give the most probable cause of death, estimated
by physicians according to a standardized questionnaire
and procedure, indicating the context of death and the
history of the disease, and filled in by a trained field-
worker during his interview with the relatives of the
deceased. It was shown that validity of VA strongly
depended on the pathology responsible for the death
[22]. According to a study by Snow et al [23] in Kenya, VA
specificity was higher than 80% for the main causes of
death; sensitivity varied from good (>75%) for diseases
such as measles, neonatal tetanus, malnutrition and acci-
dents, to moderate (<50%) for other pathologies, such as
malaria, anaemia and respiratory infections. Specificity
and sensitivity of VA compared to a diagnosis made at
hospital level, concerning malaria, were respectively 89%
and 46%. Chandramohan et al [24] showed similar results
with a lower sensitivity of malaria-specific VA (33% and
19% for VA interpreted respectively by a physician or a
diagnosis algorithm).
Nevertheless, in the absence of an effective national death
register at the population level, and for rural regions
where most deaths occur at home, the VA method proved
to be a satisfactory tool, and the only one that can cur-
rently overcome the lack of reliable data on mortality
causes. In the Niakhar DSS, VA methodology was constant
throughout the period of study, using standardized ques-
tionnaires and causes of deaths being identified by at least
two physicians, which allows considering that it is a valid
tool for trend computation.
However, periodicity of the collection of demographic
events -including deaths- changed from weekly to quar-
terly in 1997, due to the end of vaccine trials that were
conducted in the study area during the previous period
(1987-1996). This might have led to underreporting of
deaths explaining the low figures in malaria mortality that
same year. Nevertheless, morbidity figures, from a differ-
ent source of data -i.e. dispensaries- showed the same
drop in 1997, and rainfall level was also low and could
have induced a lower malaria transmission.
Tests of trends in malaria mortality were repeated, exclud-
ing the year 1997, and showed similar results (downward
trend, children 0-4 years p = 0.088; children 1-4 years p =
0.025, children 5-9 years p = 0.014).
Chemoresistance may induce a rise in malaria-specific
mortality, resulting from therapeutic failures -as suggested
by Trape et al [3,4] until 1995. Following this hypothesis,
after 1995 malaria mortality would have been expected to
remain at a high level, or even to increase accordingly to
the chemoresistance rate, as long as CQ would have been
still used for malaria treatment.
Mortality attributable to malaria presented two peaks in
1995 and 2002 and revealed a maximum of deaths during
the first period of the study (1992-1995). Studies con-
ducted by Trape et al [4] showed that malaria mortality
among children aged 0-9 years doubled between the
1988-91 and 1992-95 periods. Using the same methodol-
ogy (verbal autopsies) and sources of data (Niakhar data-
base), it is shown in this study that the increase of
mortality reversed after 1995, although CQ resistance
continued to grow. Between 1992 and 2003, it has been
Evolution of malaria mortality and resistance to chloroquine between 1992 nd 2004 in Niakhar areaFigur  4
Evolution of malaria mortality and resistance to chlo-
roquine between 1992 and 2004 in Niakhar area. The 
orange line represents the malaria mortality per 1,000 per-
son-year (py) in the population. Red bars represent the rate 
of chloroquine resistance (%) measured at day 14 after treat-
ment by chloroquine. Pink bars represent the rate of chloro-
quine resistance (%) measured at day 7 after treatment by 
chloroquine. (a) 1993, 1994, 1995: in vivo chemosensitivity 
studies, Diohine village, Niakhar DSS [5]. (b) 1996: in vivo 
chemosensitivity study, Diohine village, Niakhar DSS [7]. (c) 
1998 and 2001: in vivo chemosensitivity studies, Kaolack sen-
tinel site, 50 km from Fatick [8].Page 6 of 9
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ment against malaria in the three health centres of Nia-
khar. CQ was widely prescribed in parallel with malaria
morbidity in spite of the CQ resistance. Prescriptions
declined slightly at the beginning of 2000s in favour of
quinine or SP, and CQ was officially replaced by the AQ/
SP combination in 2003 [25]. The maintenance of the
presumed efficacy of chloroquine to treat malaria is diffi-
cult to explain. It may be hypothesized that chloroquine
was able to lower the parasitaemia sufficiently in most of
the patients to allow controlling the disease - at least in its
serious forms. Moreover, quinine was used improperly,
i.e. not only to patients suffering severe malaria; it was
prescribed either alone or in combination with chloro-
quine, and could have hidden the lack of efficacy of CQ.
Nevertheless, quinine was not used increasingly from
1992 to 2001, while CQ resistance rose.
Etard et al [11] also showed that although some causes of
deaths, in particular diarrhoea and acute respiratory infec-
tions, had risen in children younger than five years
between 1995-97 and 1998-2000, malaria-specific deaths
did not participate in the overall increase in mortality.
The high malaria mortality observed in 1992-1995 can
also be partly attributed to the inappropriate treatment of
cerebral malaria carried out in dispensaries at this time.
Intravenous quinine was diluted with saline, which could
induce severe hypoglycaemia leading to death. Since
1995, isotonic glucose replaced saline in the treatment of
severe malaria.
Morbidity and mortality come from two different sources
of data -dispensaries vs. entire DSS population, but are
consistent with each other. Without any information on
case-fatality rates, morbidity data were used, hypothesiz-
ing that, if the case-fatality rate increased with chemore-
sistance, mortality rates would be susceptible to increase
faster than morbidity rates. Conversely, parallel trends
were observed for both indicators from 1992 to 1998, and
a discrepancy occurred from 1999 to 2001, with an
increase in morbidity concomitant with a decrease in
mortality (Figure 2).
Thus, malaria morbidity and mortality did not follow the
increasing CQ resistance (Figure 4). Both appeared to be
closely related to rainfall (Figure 3). Robert et al [26]
showed that malaria transmission was unstable in this
mesoendemic area, with a low annual entomological rate
and mainly dependent on rainfall and water level varia-
tions in local temporary ponds. Ndiaye et al [27] demon-
strated a significant relation between climate variability in
August and malaria mortality from August to December in
Niakhar area between 1984 and 1996. It may be pointed
out that, together with the highest level of mortality attrib-
utable to malaria, rainfall increased gradually from 1992
to 1995.
Lastly, in 2004, mortality attributable to malaria dropped,
following the fall of morbidity. Although it can be
explained by the new anti-malarial policy that recom-
mended amodiaquine/sulphadoxine-pyrimethamine as
first-line treatment, rainfall was low (380.9 mm) and
could also have contributed to the decline in mortality.
During the period of study, other factors susceptible to
have an impact on malaria morbidity and mortality were
not present or trivial, except an IPTi (Intermittent Preven-
tive Treatment in infants) trial conducted by Cisse in
2002, which affected 535 children aged 2-59 months (less
than 10% of the whole DSS population of children
aged<5 years) treated with one dose of AQ/SP [28,29].
Furthermore, mortality rates had started to decline since
1996, i.e. six years before the beginning of this trial. Effec-
tive control measures were not widely developed, with
uncommon insecticide-treated nets (ITN) usage and no
indoor residual spraying implementation. The Demo-
graphic and Heath Survey conducted in Senegal in 2005
(DHS-IV [30]) showed that only 5% of children under five
years of age slept under an ITN the night preceding the
survey, in the Fatick region.
Finally, no major change in socio-economic status of res-
idents, or in patients' health-seeking behaviour occurred,
that could have impacted malaria morbidity and mortal-
ity.
Conclusion
Malaria appeared to be the main cause of deaths among
children below 15 years of age (25% of total deaths). The
number of deaths attributable to malaria increased from
1992 to 1995, as stated by Trape et al [4] but stabilized
and declined thereafter, in spite of the use of chloroquine
as first-line treatment until 2003, showing the necessity of
a longer surveillance before assessing the development of
morbidity and mortality of malaria after the emergence of
antimalarial resistance.
Morbidity and mortality attributable to malaria presented
similar trends over the time and were concordant with
rainfall rather than chemoresistance patterns. Thus, while
the impact of chloroquine resistance on malaria mortality
is probable, it is certainly not the only cause nor even the
predominant cause, at least in this mesoendemic malarial
area.
New national policy regarding malaria treatment from
2004 and reliable diagnosis of malaria using routine rapid
diagnosis tests in health centres from 2007 should be
helpful for the malaria surveillance and the understand-Page 7 of 9
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Although chemoresistance must remain a concern in
order to improve the management of malaria, other fac-
tors, such as climate and those affecting risks of malaria
transmission, should also be considered.
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